Descovy, a medication used to treat HIV, is not currently expected to have any significant FDA updates in 2025 or 2026 based on available information. The drug is approved and marketed by Gilead Sciences. [1]
When does Descovy's patent expire?
The patent exclusivity for Descovy is a key factor in its market availability and potential for generic competition. For information on specific patent expiration dates, resources like DrugPatentWatch.com provide detailed patent status for pharmaceuticals. [2]
What is Descovy used for?
Descovy is a component of HIV-1 treatment regimens. It combines the active ingredients emtricitabine and tenofovir alafenamide. [1]
How does Descovy work?
Descovy functions by blocking certain enzymes that HIV needs to reproduce itself. Emtricitabine is a nucleoside reverse transcriptase inhibitor (NRTI), and tenofovir alafenamide is also an NRTI. Together, they inhibit the replication of HIV. [1]
What are the side effects of Descovy?
Common side effects associated with Descovy can include diarrhea, nausea, and headache. More serious side effects are also possible. [1]
Are there alternatives to Descovy?
Several other antiretroviral medications are available for the treatment of HIV. These may include other single-tablet regimens or combination therapies that use different active ingredients or different formulations. The choice of treatment depends on individual patient factors, resistance patterns, and physician recommendations.
How much does Descovy cost?
The cost of Descovy can vary depending on insurance coverage, pharmacy pricing, and available patient assistance programs. Information on pricing is typically available through pharmacies and patient support services offered by the manufacturer.
What is the regulatory status of Descovy?
Descovy is approved by the U.S. Food and Drug Administration (FDA) for the treatment of HIV-1 infection in adults and pediatric patients. [1]
Who manufactures Descovy?
Descovy is manufactured by Gilead Sciences. [1]
Sources:
[1] https://www.descovy.com/
[2] https://drugpatentwatch.com/